Peterborough and Stamford Hospitals NHS Foundation Trust
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk SubjectsA 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial HypercholesterolemiaA Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
P6153
Peterborough and Stamford Hospitals NHS Foundation Trust
name
Peterborough and Stamford Hospitals NHS Foundation Trust
@en
type
label
Peterborough and Stamford Hospitals NHS Foundation Trust
@en
prefLabel
Peterborough and Stamford Hospitals NHS Foundation Trust
@en
P214
P244
P131
P214
P2427
grid.440192.a
P244
nb2009019522
P4527
P576
2017-03-31T00:00:00Z
P6782
P7859
lccn-nb2009019522
P8167
peterborough_and_stamford_hospitals_nhs_foundation_trust